Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-κB signaling pathway

References

• Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, Wilkins E, Wright L, Vos R, Bax J. et al. European society of cardiology: cardiovascular disease statistics 2017. Eur Heart J. 2018;39(7):508–19. doi:10.1093/eurheartj/ehx628.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D’Avino R Jr, De Leon J. CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis. 2018;278:49–59. doi:10.1016/j.atherosclerosis.2018.08.046.
   PubMed Web of Science ®Google Scholar
• Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM, Towler DA. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697–711. doi:10.1161/CIRCRESAHA.
   PubMed Web of Science ®Google Scholar
• Rogers MA, Aikawa E. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261–274. doi:10.1038/s41569-018-0123-8.
   PubMed Web of Science ®Google Scholar
• Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114(4):590–600. doi:10.1093/cvr/cvy010.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao X, Wu H. Arterial stiffness: a focus on vascular calcification and its link to bone mineralization. Arterioscler Thromb Vasc Biol. 2020;40(5):1078–1093. doi:10.1161/ATVBAHA.120.313131.
   PubMed Web of Science ®Google Scholar
• Li Z, Wu J, Zhang X, Ou C, Zhong X, Chen Y, Lu L, Liu H, Li Y, Liu X. et al. CDC42 promotes vascular calcification in chronic kidney disease. J Pathol. 2019;249(4):461–471. doi:10.1002/path.5334.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Yang P, Liu X, Lu L, Chen Y, Zhong X, Li Z, Liu H, Ou C. et al. Trimethylamine-N-Oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-κB (nuclear factor κB) signals. Arterioscler Thromb Vasc Biol. 2020;40(3):751–765. doi:10.1161/ATVBAHA.119.313414.
   PubMed Web of Science ®Google Scholar
• Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017;13(7):429–442. doi:10.1038/nrneph.2017.60.
   PubMed Web of Science ®Google Scholar
• Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117(22):2938–2948. doi:10.1161/CIRCULATIONAHA.107.743161.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney International. 2013;83(2):308–315. doi:10.1038/ki.2012.345.
   PubMed Web of Science ®Google Scholar
• Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, Martin GS. The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Crit Care. 2020;24(1):278. doi:10.1186/s13054-020-02989-1.
   PubMed Web of Science ®Google Scholar
• Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2023;20(1):24–37. doi:10.1038/s41569-022-00737-2.
   PubMed Web of Science ®Google Scholar
• Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120(7):1183–1196. doi:10.1161/CIRCRESAHA.117.309715.
   PubMed Web of Science ®Google Scholar
• Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670. doi:10.1681/ASN.2013080905.
   PubMed Web of Science ®Google Scholar
• Rodrigues FG, Ormanji MS, Heilberg IP, Bakker SJL, de Borst MH. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Eur J Clin Invest. 2021;51(9):e13588. doi:10.1111/eci.13588.
   PubMed Web of Science ®Google Scholar
• Glorieux G, Nigam SK, Vanholder R, Verbeke F. Role of the microbiome in gut-heart-kidney cross talk. Circ Res. 2023;132(8):1064–1083. doi:10.1161/CIRCRESAHA.123.321763.
   PubMed Web of Science ®Google Scholar
• Wheeler DC, Stefánsson BV, Jongs N, Chertow GM, Greene T, Hou FF, McMurray JJV, Correa-Rotter R, Rossing P, Toto RD. et al. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9(1):22–31. doi:10.1016/S2213-8587(20)30369-7.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am College Cardiol. 1990;15(4):827–832. doi:10.1016/0735-1097(90)90282-t.
   PubMed Web of Science ®Google Scholar
• Pedrosa JF, Barreto SM, Bittencourt MS, Ribeiro ALP. Anatomical references to evaluate thoracic aorta calcium by computed tomography. Curr Atheroscler Rep. 2019;21(12):51. doi:10.1007/s11883-019-0811-9.
   PubMed Web of Science ®Google Scholar
• Feng L, Que D, Li Z, Zhong X, Yan J, Wei J, Zhang X, Yang P, Ou C, Chen M. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clin Sci (Lond). 2021;135(21):2483–2502. doi:10.1042/CS20210259.
   PubMed Web of Science ®Google Scholar
• Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest. 2019;99(3):346–357. doi:10.1038/s41374-018-0091-y.
   PubMed Web of Science ®Google Scholar
• Yu C, Zhou B, Xia X, Chen S, Deng Y, Wang Y, Wu L, Tian Y, Zhao B, Xu H. et al. Prevotella copri is associated with carboplatin-induced gut toxicity. Cell Death Disease. 2019;10(10):714. doi:10.1038/s41419-019-1963-9.
   PubMedGoogle Scholar
• Ye Y, Chen A, Li L, Liang Q, Wang S, Dong Q, Fu M, Lan Z, Li Y, Liu X. et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 2022;102(6):1259–1275. doi:10.1016/j.kint.2022.07.034.
   PubMed Web of Science ®Google Scholar
• Sherrard LJ, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Muhlebach MS, Wolfgang MC, Gilpin DF, Elborn JS, Schneiders T. et al. Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis. J Antimicrob Chemother. 2013;68(10):2369–2374. doi:10.1093/jac/dkt191.
   PubMed Web of Science ®Google Scholar
• Carloni S, Bertocchi A, Mancinelli S, Bellini M, Erreni M, Borreca A, Braga D, Giugliano S, Mozzarelli AM, Manganaro D. et al. Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science. 2021;374(6566):439–448. doi:10.1126/science.abc6108.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang M, Li J, Liang J, Yang M, Xia G, Ren Y, Zhou H, Wu Q, He Y. et al. Gut microbiota is causally associated with poststroke cognitive impairment through lipopolysaccharide and butyrate. J Neuroinflammation. 2022;19(1):76. doi:10.1186/s12974-022-02435-9.
   PubMed Web of Science ®Google Scholar
• Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9):e006347. doi:10.1161/JAHA.117.006347.
   PubMed Web of Science ®Google Scholar
• Gabriel CL, Ferguson JF. Gut microbiota and microbial metabolism in early risk of cardiometabolic disease. Circ Res. 2023;132(12):1674–1691. doi:10.1161/CIRCRESAHA.123.322055.
   PubMed Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553–570. doi:10.1161/CIRCRESAHA.120.316242.
   PubMed Web of Science ®Google Scholar
• Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020;8(1):36. doi:10.1186/s40168-020-00821-0.
   PubMed Web of Science ®Google Scholar
• Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E, He Z, Zhong W, Fan Y, Zhang L. et al. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol. 2017;18(1):142. doi:10.1186/s40168-020-00821-0.
   PubMedGoogle Scholar
• Tett A, Huang KD, Asnicar F, Fehlner-Peach H, Pasolli E, Karcher N, Armanini F, Manghi P, Bonham K, Zolfo M. et al. The prevotella copri complex comprises four distinct clades underrepresented in westernized populations. Cell Host Microbe. 2019;26(5):666–679.e7. doi:10.1016/j.chom.2019.08.018.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M. et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016;68(11):2646–2661. doi:10.1002/art.39783.
   PubMed Web of Science ®Google Scholar
• Olas B. Probiotics, prebiotics and synbiotics-A promising strategy in prevention and treatment of cardiovascular diseases? Int J Mol Sci. 2020;21(24):9737. doi:10.3390/ijms21249737.
   PubMed Web of Science ®Google Scholar
• Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR. et al. Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. Hepatology. 2022;75(4):955–967. doi:10.1002/hep.32197.
   PubMed Web of Science ®Google Scholar
• Chen C, Fang S, Wei H, He M, Fu H, Xiong X, Zhou Y, Wu J, Gao J, Yang H. et al. Prevotella copri increases fat accumulation in pigs fed with formula diets. Microbiome. 2021;9(1):175. doi:10.1002/hep.32197.
   PubMed Web of Science ®Google Scholar
• Blusztajn JK, Slack BE, Mellott TJ. Neuroprotective actions of dietary choline. Nutrients. 2017;9(8):815. doi:10.3390/nu9080815.
   PubMed Web of Science ®Google Scholar
• Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation. 2019;16(1):180. doi:10.1186/s12974-019-1564-7.
   PubMed Web of Science ®Google Scholar
• Yaker L, Tebani A, Lesueur C, Dias C, Jung V, Bekri S, Guerrera IC, Kamel S, Ausseil J, Boullier A. Extracellular vesicles from LPS-Treated macrophages aggravate smooth muscle cell calcification by propagating inflammation and oxidative stress. Front Cell Dev Biol. 2022;10:823450. doi:10.3389/fcell.2022.823450.
   PubMed Web of Science ®Google Scholar
• Needham BD, Trent MS. Fortifying the barrier: the impact of lipid a remodelling on bacterial pathogenesis. Nat Rev Microbiol. 2013;11(7):467–481. doi:10.1038/nrmicro3047.
   PubMed Web of Science ®Google Scholar
• Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233–1261. doi:10.1007/s00018-020-03656-y.
   PubMed Web of Science ®Google Scholar
• Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G, Di Daniele N. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017;281(5):471–482. doi:10.1111/joim.12605.
   PubMed Web of Science ®Google Scholar
• Lan Z, Chen A, Li L, Ye Y, Liang Q, Dong Q, Wang S, Fu M, Li Y, Liu X. et al. Downregulation of HDAC9 by the ketone metabolite β-hydroxybutyrate suppresses vascular calcification. J Pathol. 2022;258(3):213–226. doi:10.1002/path.5992.
   PubMed Web of Science ®Google Scholar
• Voelkl J, Luong TT, Tuffaha R, Musculus K, Auer T, Lian X, Daniel C, Zickler D, Boehme B, Sacherer M. et al. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. J Clin Invest. 2018;128(7):3024–3040. doi:10.1172/JCI96477.
   PubMed Web of Science ®Google Scholar
• Bryant CE, Spring DR, Gangloff M, Gay NJ. The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol. 2010;8(1):8–14. doi:10.1038/nrmicro2266.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao Y, Wang X, Lin Y, Zhao W, Wu D, Pan J, Luo W, Wang Y, Liang G. FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway. Cell Death Disease. 2022;13(7):589. doi:10.1038/s41419-022-05046-7.
   PubMed Web of Science ®Google Scholar